Cingulate (CING) Research & Development (2021 - 2026)
Cingulate's (CING) quarterly Research & Development came in at $1.5 million in Q2 2026, down 44.95% on a YoY basis from $2.7 million in Q2 2025, and down 25.73% quarter-over-quarter from $2.0 million in Q4 2025.
Powered by 
Analysis
Cingulate (CING) Research & Development (2021 - 2026) Analysis & Trends
Cingulate (CING) has reported Research & Development for 6 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Research & Development fell 44.95% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2026 stood at $9.0 million (down 15.38% YoY), and the FY2025 full-year result was $9.8 million, up 3.48% from the prior year.
- Research & Development eased to $1.5 million in Q2 2026 per CING's latest filing, from $2.0 million in the prior quarter.
- Across five years, Research & Development topped out at $5.0 million in Q4 2023 and bottomed at $1.4 million in Q3 2024.
- Historically, Research & Development has averaged $2.7 million across 5 years, with a median of $2.2 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Research & Development surged 391.06% in 2022, then sank 63.59% in 2024.
- Over 5 years, Research & Development stood at $1.9 million in 2022, then jumped by 158.06% to $5.0 million in 2023, then retreated by 13.16% to $4.3 million in 2024, then sank by 53.75% to $2.0 million in 2025, then decreased by 25.73% to $1.5 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $1.5 million, $2.0 million, and $2.8 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 2.81 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 2.96 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | -2.60 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 394.92 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 612.28 Mn |
| 10 | Cingulate | 72.81 Mn | 72.81 Mn | - | 1.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 4.33 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | 4.98 Mn |
| Sep 30, 2023 | 3.92 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | 2.13 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 2.12 Mn |
| Jun 30, 2022 | 2.18 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 5.79 Mn |
| Jun 30, 2021 | 793,587.00 |
API Access
Cingulate Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CING&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CING", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CING&period=max&api_key=YOUR_API_KEY");
const data = await res.json();